ID18726A - Melanoma yang disesuaikan analog-analog peptida vaksin-vaksin yang melawan melanoma - Google Patents

Melanoma yang disesuaikan analog-analog peptida vaksin-vaksin yang melawan melanoma

Info

Publication number
ID18726A
ID18726A IDP972391A ID972391A ID18726A ID 18726 A ID18726 A ID 18726A ID P972391 A IDP972391 A ID P972391A ID 972391 A ID972391 A ID 972391A ID 18726 A ID18726 A ID 18726A
Authority
ID
Indonesia
Prior art keywords
melanoma
peptides
vaccines against
ctl
improved immunogenicity
Prior art date
Application number
IDP972391A
Other languages
English (en)
Inventor
Carl Gustav Figdor
Gosse Jan Adema
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ID18726A publication Critical patent/ID18726A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3053—Skin, nerves, brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IDP972391A 1996-07-11 1997-07-10 Melanoma yang disesuaikan analog-analog peptida vaksin-vaksin yang melawan melanoma ID18726A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96201945 1996-07-11

Publications (1)

Publication Number Publication Date
ID18726A true ID18726A (id) 1998-05-07

Family

ID=8224171

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972391A ID18726A (id) 1996-07-11 1997-07-10 Melanoma yang disesuaikan analog-analog peptida vaksin-vaksin yang melawan melanoma

Country Status (10)

Country Link
EP (1) EP0934405B1 (id)
JP (2) JP4386463B2 (id)
AT (1) ATE206759T1 (id)
AU (1) AU3693897A (id)
CA (1) CA2259944C (id)
DE (1) DE69707296T2 (id)
ES (1) ES2165619T3 (id)
ID (1) ID18726A (id)
WO (1) WO1998002538A1 (id)
ZA (1) ZA975858B (id)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA975858B (en) * 1996-07-11 1998-09-01 Akzo Nobel Nv Melanoma associated peptide analogues and vaccines against melanoma
US20040156861A1 (en) 1996-07-11 2004-08-12 Figdor Carl Gustav Melanoma associated peptide analogues and vaccines against melanoma
FR2763071B1 (fr) * 1997-05-07 2003-05-16 Centre Nat Rech Scient Analogues peptidiques, et leurs utilisations notamment dans des compositions pharmaceutiques et pour le diagnostic
CA2295321C (en) * 1997-06-23 2008-01-29 Ludwig Institute For Cancer Research Isolated nona- and decapeptides which bind to hla molecules, and the use thereof
AU1013601A (en) 1999-10-22 2001-05-08 Aventis Pasteur Limited Method of inducing and/or enhancing an immune response to tumor antigens
CA2438505A1 (en) * 2001-02-14 2002-09-12 Genzyme Corporation Altered peptide ligands
CA2674445C (en) 2007-01-12 2016-06-07 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Gp100-specific t cell receptors and related materials and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE272113T1 (de) * 1994-02-16 2004-08-15 Crucell Holland Bv Melanoma-assoziierte antigene, epitope davon und impstoffe gegen melanoma
EP0756604A1 (en) * 1994-04-22 1997-02-05 THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services Melanoma antigens
ZA975858B (en) * 1996-07-11 1998-09-01 Akzo Nobel Nv Melanoma associated peptide analogues and vaccines against melanoma

Also Published As

Publication number Publication date
ATE206759T1 (de) 2001-10-15
JP4386463B2 (ja) 2009-12-16
JP2000515739A (ja) 2000-11-28
CA2259944C (en) 2011-06-28
CA2259944A1 (en) 1998-01-22
ES2165619T3 (es) 2002-03-16
DE69707296T2 (de) 2002-07-25
WO1998002538A1 (en) 1998-01-22
EP0934405A1 (en) 1999-08-11
JP2009178166A (ja) 2009-08-13
ZA975858B (en) 1998-09-01
AU3693897A (en) 1998-02-09
EP0934405B1 (en) 2001-10-10
JP5198354B2 (ja) 2013-05-15
DE69707296D1 (de) 2001-11-15

Similar Documents

Publication Publication Date Title
FI950665A (fi) Melanoomaan liittyvä antigeeninen polypeptidi, sen epitooppeja ja melanoomarokotteita
HU9500571D0 (en) Retro-, inverso-, and retro-inverso synthetic peptide analogues
PL347977A1 (en) Novel methods for therapeutic vaccination
NO994983L (no) Fremgangsmåte for fremstilling av anti-humane antigenreseptorer, samt anvendelse av disse
WO2006014579A3 (en) Enhancing class i antigen presentation with synthetic sequences
CY1107706T1 (el) Πεπτιδια ανταγωνιστες καρκινοεμβρυονικου αντιγονου (cea)
HK1093314A1 (en) Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens
SE8700805D0 (sv) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas
ID18726A (id) Melanoma yang disesuaikan analog-analog peptida vaksin-vaksin yang melawan melanoma
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
MX2023004465A (es) Composiciones basadas en virus y métodos para redirigir respuestas inmunitarias preexistentes mediante su uso para el tratamiento del cáncer.
ATE344052T1 (de) Protein-verabreichungssystem, das dem menschlichen papillomavirus ähnliche partikel benützt.
AU2003241127A8 (en) Membrane-anchored beta2 microglobulin covalently linked to mhc class i peptide epitopes
HUP0202770A2 (hu) Humán papillómavírus oltóanyag
NZ515332A (en) Lawsonia derived gene and related SodC polypeptides, peptides and proteins and their uses
SE8700466D0 (sv) Vaccines against melanoma
EP1502602A3 (en) Methods for therapeutic vaccination
Lucchese et al. protEomic pEptidE scan of porphyromonas gingiValis fima typE ii for sEarching potEntial b-cEll EpitopEs
RU92004487A (ru) Днк, полипептид, вакцина, вектор, микроорганизм, клетка насекомого, реагент, способы лечения и профилактики, способ обнаружения антигенов